ArticleDiscover oncology2025

Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinoma.

Maximilian Haack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.